sciatic nerve block in the popliteal fossa and femoral nerve block in the adductor canal. The Centers for Medicare and Medicaid Services issued a permanent product-specific J-code (J0666 ...

Pacira BioSciences settles US patent litigations with three companies for Exparel: Brisbane, California Wednesday, April 9, 2025, 15:00 Hrs [IST] Pacira BioSciences, Inc, the indu ...

Pacira BioSciences stock rises as it settles Exparel patent litigation with several generic players protecting the drug's exclusivity in the United States at least until 2030.

and a sciatic nerve block in the popliteal fossa for postsurgical pain management; ZILRETTA ® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular ...

Nine employees received stock options to purchase an aggregate of 23,100 shares of Pacira common stock and 18 employees received restricted stock units for an aggregate of 43,400 shares of Pacira ...